June 9, 2026
Gad Berdugo, MSc Eng., MBA, joins as an independent board member in connection with an investment from Explorium Capital LLC through the Cane Angel Network. He brings over 30 years of leadership in biotechnology, RNA therapeutics, and capital markets — including senior roles at Editas Medicine, Abbott Laboratories, and Baxter International.